FANJ
ATRS

Financial Architects (New Jersey)’s Antares Pharma, Inc. ATRS Stock Holding History

Financial Architects (New Jersey)’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$3K – 1545
2018
Q3 		$3K Buy
+1,000
New +$3.09K ﹤0.01% 1311

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Architects (New Jersey)'s ATRS Position: Q4 2018 in Review

Financial Architects (New Jersey) sold out of Antares Pharma, Inc. (ATRS) in Q4 2018, closing a stake of 1,000 shares — an estimated $3K sold.

Financial Architects (New Jersey) first reported a position in ATRS in Q3 2018 and held it in 1 quarter. The position peaked at $3K in Q3 2018. 120 funds tracked by Wall St. Rank hold ATRS as of Q4 2018.

  • Financial Architects (New Jersey) reported no remaining Antares Pharma, Inc. position as of Q4 2018 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 1,000 Antares Pharma, Inc. shares in Q4 2018, an estimated $3K.
  • Financial Architects (New Jersey) first reported a position in Antares Pharma, Inc. in Q3 2018 and held it in 1 quarter.
  • Financial Architects (New Jersey)'s Antares Pharma, Inc. position peaked at $3K in Q3 2018.
  • 120 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2018.

Based on Financial Architects (New Jersey)'s 13F filing for Q4 2018, filed 1 Feb 2019.